ContractStock and Asset Purchase and License Agreement • May 5th, 2020 • New York
EX-2.1 2 a50756252ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 CONFIDENTIAL TREATMENT REQUESTED Portions of this exhibit indicated by “[***]” have been omitted, and such omitted portions have been filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. STOCK AND ASSET PURCHASE AND LICENSE AGREEMENT Among MERCK & CO., INC., MERCK SHARP & DOHME CORP., INSPIRE PHARMACEUTICALS, INC., and OAK PHARMACEUTICALS, INC. November 15, 2013 CONFIDENTIAL TREATMENT REQUESTED Portions of this exhibit indicated by “[***]” have been omitted, and such omitted portions have been filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. TABLE OF CONTENTS
